|
|
|
|
Vol. 13, Issue 12, 4443-4455, December 2002
Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Submitted July 16, 2002; Revised August 27, 2002; Accepted September 9, 2002| |
ABSTRACT |
|---|
|
|
|---|
Ycf1p is the prototypical member of the yeast multidrug resistance-associated protein (MRP) subfamily of ATP-binding cassette (ABC) transporters. Ycf1p resides in the vacuolar membrane and mediates glutathione-dependent transport processes that result in resistance to cadmium and other xenobiotics. A feature common to many MRP proteins that distinguishes them from other ABC transporters is the presence of a hydrophobic N-terminal extension (NTE), whose function is not clearly established. The NTE contains a membrane spanning domain (MSD0) with five transmembrane spans and a cytosolic linker region (L0). The goal of this study was to determine the functional significance of the NTE of Ycf1p by examining the localization and functional properties of Ycf1p partial molecules, expressed either singly or together. We show that MSD0 plays a critical role in the vacuolar membrane trafficking of Ycf1p, whereas L0 is dispensable for localization. On the other hand, L0 is required for transport function, as determined by monitoring cadmium resistance. We also examine an unusual aspect of Ycf1p biology, namely, the posttranslational proteolytic processing that occurs within a lumenal loop of Ycf1p. Processing is shown to be Pep4p dependent and thus serves as a convenient marker for proper vacuolar localization. The processed fragments associate with each other, suggesting that these natural cleavage products contribute together to Ycf1p function.
| |
INTRODUCTION |
|---|
|
|
|---|
ATP-binding cassette (ABC) proteins comprise a ubiquitous protein
superfamily, present in microbes, plants, and animals, whose members
play key roles in a variety of cellular transport processes (Higgins,
1992
; Decottignies and Goffeau, 1997
; Taglicht and Michaelis, 1998
;
Dean et al., 2001a
,b
; Sanchez-Fernandez et al.,
2001
). One group of ABC transporters, the multidrug
resistance-associated protein (MRP) subfamily (also designated the ABCC
subfamily) has recently been the focus of numerous studies. MRP
proteins function in normal physiological processes, such as the
leukotriene C4-mediated inflammatory response and
bile pigment elimination, and can mediate cellular detoxification by
excreting drugs or cellular metabolites in the form of glutathione-,
glucuronide-, or sulfate-conjugates (Cole and Deeley, 1998
; Hipfner
et al., 1999
; Konig et al., 1999
; Borst et
al., 2000
; Gottesman et al., 2002
). Alternatively,
certain MRP substrates may be cotransported or noncovalently complexed with glutathione during their transport.
Members of the MRP subfamily share a conserved architecture with other
ABC transporters (Bakos et al., 1996
; Loe et al.,
1996
). The ABC "core" domain consists of two homologous halves,
each half containing a membrane spanning domain (MSD) with six
transmembrane spans, and a nucleotide binding domain (NBD) that
includes three conserved motifs designated the Walker A, Walker B, and
signature motifs. The halves are connected by a linker (L1). For many
ABC transporters, including the well-characterized human
multidrug-resistance protein P-glycoprotein (encoded by MDR1),
the ABC core domain is sufficient for proper localization, ATP
hydrolysis, and substrate recognition. A distinguishing feature of many
members of the MRP subfamily is an additional N-terminal extension
(NTE) that is very hydrophobic (Bakos et al., 1996
; Hipfner
et al., 1997
; Borst et al., 2000
). The NTE is
surprisingly substantial (~275 aa) and is comprised of a membrane
spanning domain (MSD0) with five predicted transmembrane helices, plus
a cytoplasmic linker region (L0). The functional significance of the
N-terminal extension is not clearly understood and remains a major
issue in the MRP field. Several recent studies have focused on
understanding the roles of the MSD0 and L0 subdomains of the NTE in
human MRP1 (Bakos et al., 1998
; Gao et al., 1998
;
Bakos et al., 2000
; Qian et al., 2001
). These
studies showed that the linker region (L0) is necessary for the plasma
membrane localization and functional activity of MRP1. Surprisingly,
however, no role for the membrane spanning domain (MSD0) of MRP1 has
yet been determined, because constructs missing solely MSD0 show a
pattern that is indistinguishable from wild-type in terms of
basolateral membrane localization and transport activity (Bakos
et al., 1998
). In contrast, it was recently reported for
human MRP2 that MSD0 plays a critical role in the proper routing to or
stable association of MRP2 with the apical membrane (Fernandez et
al., 2002
).
The product of the YCF1 gene, the yeast cadmium factor
Ycf1p, is the best-studied MRP subfamily member in yeast. Ycf1p, which resides in the vacuolar membrane, detoxifies the yeast cell of heavy
metals and xenobiotics by transporting glutathione-conjugates and
complexes into the vacuole where they are sequestered and/or further
metabolized (Szczypka et al., 1994
; Li et al.,
1996
; Chaudhuri et al., 1997
; Li et al., 1997
).
Human MRP1 can complement the biochemical transport and cadmium
resistance defects of a ycf1 mutant, providing compelling
evidence of mechanistic conservation (Tommasini et al.,
1996
). Ycf1p therefore serves as an excellent model protein to dissect
the functional roles of distinct domains of members of the MRP
subfamily. Like human MRP1 and MRP2, the domain arrangement of Ycf1p
consists of a typical ABC core domain, which includes two MSDs, and two
NBDs separated by a linker (L1) as well as the additional NTE (Figure
1A).
|
The goal of the present study was to assess the function of the
N-terminal extension in Ycf1p. To do so, we constructed partial molecules of Ycf1p and determined their functional ability by assaying
tolerance to cadmium. We show that MSD0 is required for the efficient
localization of Ycf1p to the vacuolar membrane. This is the first
demonstration of a role for MSD0 in the trafficking of a yeast MRP
transporter and parallels the finding that MSD0 is important for the
trafficking of human MRP2 (Fernandez et al., 2002
). On the
other hand, our results indicate that L0 is not required for
localization of Ycf1p but is instead essential for Ycf1p-mediated
cadmium resistance (a similar functional role has been previously
demonstrated for L0 of MRP1). In this study, we also reexamined an
intriguing aspect of Ycf1p biology, namely, its posttranslational
proteolytic processing that was first reported by Wemmie and
Moye-Rowley (1997)
. Our studies show that cleavage of Ycf1p occurs
within a lumenal loop of MSD1 and is dependent on the master vacuolar
protease Pep4p, thus providing a convenient marker for successful
trafficking of Ycf1p to the vacuolar membrane. Furthermore, our
analysis indicates that once processing occurs, the N- and C-terminal
cleavage products remain associated with one another, suggesting that
both cleavage products contribute to activity of Ycf1p.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Yeast Strains, Media, and Growth Conditions
Yeast strains used in this study are listed in Table
1. Plate and liquid drop-out media were
prepared as described previously (Michaelis and Herskowitz, 1988
). The
plates used for the cadmium spot tests were prepared by adding the
indicated concentration of CdSO4 to the minimal
medium immediately before pouring the plates. Cultures were grown at
30°C except where indicated. All yeast transformations were performed
as described previously (Elble, 1992
).
|
Plasmid Constructions
Plasmids used in this study are listed in Table
2. To epitope tag the N-terminal region
of Ycf1p, we used a triply iterated epitope from influenza
hemagglutinin (HA) as a NotI fragment in the vector
GTEP1 (Tyers et al., 1992
). First, a NotI
restriction site was introduced after amino acid 63 of Ycf1p in pSM1753
(2µ URA3 YCF1-GFP) (Sharma et al., 2002
)
to yield pSM1772 (2µ URA3 YCF1-GFP), which is identical to
pSM1753 except for the addition of the NotI site. The triple
HA epitope tag was subcloned into NotI-digested pSM1772. The
resulting plasmid, pSM1774 (2µ URA3 YCF1-HA-GFP), contains
a triple HA epitope tag in the first cytosolic loop of Ycf1p and GFP
fused to the C terminus of Ycf1p (Figure 4A). The addition of the
triple HA epitope tag was confirmed by DNA sequence analysis.
|
The Ycf1p partial molecules were constructed by recombinational cloning
(Oldenburg et al., 1997
). Each N-terminal partial molecule
has a triple HA epitope tag at residue 63 in the first cytosolic loop.
The C-terminal partial molecules have green fluorescent protein (GFP)
fused immediately before the stop codon. To construct the plasmids
pSM1869 (2µ URA3 ycf1
209-1515-HA; MSD0) and
pSM1870 (2µ URA3 ycf1
272-1515-HA; MSD0-L0), fragments
of YCF1 were amplified by polymerase chain reaction (PCR)
from pSM1753 and then recombined into
AgeI-PmlI-digested pSM1774. The corresponding
C-terminal partial molecules of Ycf1p containing amino acids 209-1515 or 272-1515 were constructed by PCR amplification of a fragment of YCF1 from pJAW50 (2µ TRP1 YCF1) (Wemmie
et al., 1994
), followed by recombination of each product
into AatII-digested pSM1774. The resulting plasmids were
pSM1871 (2µ URA3 ycf1
2-208-GFP; L0-
Ycf1p) and pSM1872 (2µ URA3 ycf1
2-271-GFP;
Ycf1p). To construct LEU2 versions of these
C-terminal partial molecules, PvuI fragments from pSM1871
and pSM1872 were subcloned into PvuI-digested pRS425 (2µ LEU2) (Sikorski and Hieter, 1989
) generating pSM1873
(2µ LEU2 ycf1
2-208-GFP; L0-
Ycf1p) and
pSM1874 (2µ LEU2 ycf1
2-271-GFP;
Ycf1p). A LEU2 version of full-length
YCF1-HA-GFP was constructed by subcloning a PvuI
fragment from pSM1774 into PvuI-digested pRS425 to yield
pSM1881 (2µ LEU2 YCF1-HA-GFP).
A deletion of the 13-amino acid region predicted to form a helical
wheel within L0 was created by recombinational cloning of a
YCF1 PCR product containing an engineered deletion of amino acids 223-235 into AgeI-linearized pSM1774, thereby
yielding pSM1889 (2µ URA3 ycf1
223-235-HA-GFP). To
construct a LEU2 version of ycf1
223-235-HA-GFP, an AatII-StuI
fragment from pSM1889 was subcloned into
AatII-StuI-digested pSM1881, generating pSM1890
(2µ LEU2 ycf1
223-235-HA-GFP). The partial molecules and
helical wheel deletion described above were confirmed by DNA sequence
analysis. Note that sequence analysis revealed a conservative
substitution of K270R in pSM1870 that was presumably generated during
the plasmid construction.
A detailed description of plasmid constructions have been described
previously (Mason, 2002
) and can be furnished upon request.
Antibodies
The rabbit anti-GFP polyclonal antibody was a gift from R. Jensen (Johns Hopkins University School of Medicine, Baltimore, MD). The mouse anti-GFP monoclonal antibody (mAb) was purchased from CLONTECH (Palo Alto, CA). The 3F-10 rat anti-HA mAb was purchased from Roche Applied Sciences (Indianapolis, IN) and the 10D7-A7-B2 mouse anti-Vph1p mAb was purchased from Molecular Probes (Eugene, OR). The horseradish peroxidase-conjugated secondary antibodies (donkey anti-rabbit Ig, sheep anti-mouse Ig, and sheep anti-rat Ig) used for immunoblotting were purchased from Amersham Biosciences (Piscataway, NJ).
Fluorescence Microscopy
To examine the localization of Ycf1p-GFP, cells were grown overnight to saturation in minimal medium, and then subcultured at a 1:1000 dilution in minimal medium and grown overnight at 30°C to an OD600 of ~0.7. Log phase cells were examined at 100× magnification on poly-lysine-coated slides by using an Axioskop microscope equipped with fluorescence and Nomarski optics (Carl Zeiss, Thornwood, NY). Images were captured with a Cooke charge-coupled device camera and IP Lab Spectrum Software (Biovision Technologies, Exton, PA).
Immunoblotting Analysis
Cell extracts and immunoblots were prepared as
described previously (Fujimura-Kamada et al., 1997
) except
that samples were either heated at 65°C for 10 min before
electrophoresis (Figure 2) or not heated
to minimize aggregation (Figure 5). Crude yeast cell extracts (0.4 OD600 cell equivalents per lane) were resolved by
either 8% (Figures 2 and 5B) or 10% (Figure 5C) SDS-PAGE and transferred to nitrocellulose. The primary antibodies used were rabbit
anti-GFP (1:5000), mouse anti-GFP (1:670), and rat anti-HA (1:400).
|
Cycloheximide Chase Experiments
Logarithmically growing cells (10.0 OD600
units) were harvested and resuspended in 2.0 ml of synthetic complete
drop-out medium, to which 10 µl of 1 mg/ml cycloheximide was added.
Aliquots (2.5 OD600 units) were collected after
incubation at 30°C for 0, 10, 30, and 60 min and added to an equal
volume of ice-cold 2× azide stop mix (40 mM cysteine, 40 mM
methionine, 20 mM sodium azide). After harvesting the cells, proteins
were precipitated and analyzed by immunoblotting as
described previously (Fujimura-Kamada et al., 1997
) except
that samples were heated at 65°C for 10 min before electrophoresis,
and 0.5 OD600 cell equivalents per lane were
resolved by 10% SDS-PAGE. The primary antibodies used were rabbit
anti-GFP (1:5000) and rat anti-HA (1:1000).
Metabolic Labeling and Immunoprecipitation
Proteins were metabolically labeled and immunoprecipitated as
described previously (Loayza et al., 1998
) except that 50 µl of extract in sample buffer was brought up to 1.0 ml with dilution buffer and 2.0 µl of the rabbit anti-GFP antibody was added to each
sample of 2.5 OD600 units of cells.
Immunoprecipitates were dissociated from the protein A-Sepharose beads
by the addition of 30 µl of 2× Laemmli sample buffer and incubated
at 37°C for 10 min before electrophoresis.
The amount of the full-length and C-terminal cleavage product of Ycf1p remaining after each time point was determined using PhosphorImager analysis and ImageQuant software (Molecular Dynamics, Sunnyvale, CA). The data were graphed using the KaleidaGraph software (Synergy Software, Reading, PA).
Yeast Cell Membrane Preparations and Coimmunoprecipitation Assay
Logarithmically growing cells (100 OD600
units) were harvested, washed once with cold 10 mM sodium azide, and
resuspended to 10 OD600 units per milliliter in
cold 100 mM Tris and 10 mM dithiothreitol, pH 9.6. After a 10-min
incubation on ice, cells were recovered by centrifugation and
resuspended to 25 OD600 units per milliliter in
oxalyticase buffer (50 mM KPi, pH 7.5, 1.4 M sorbitol, 10 mM sodium azide). To generate spheroplasts, oxalyticase (Enzogenetics, Corvallis, OR) was added at 1 µg/OD600 units and the cells were incubated at
30°C in a shaking water bath for 40 min. The resulting spheroplasts
were chilled on ice for 5 min, harvested by centrifugation, and
resuspended to 500 OD600 units per milliliter in
cold lysis buffer (10 mM HEPES, pH 7.0, 0.8 M sorbitol, 1 mM EDTA,
0.02% sodium azide) containing protease inhibitors (3 µg/ml
leupeptin, pepstatin, and chymostatin; 2 µg/ml aprotinin; and 1 mM
phenylmethylsulfonyl fluoride). The cells were lysed by vortexing with
zirconium beads in 10 1-min pulses at 4°C. The lysate was cleared
twice of unbroken cells and large cellular fragments by centrifugation
(500 × g for 10 min at 4°C). Membranes were
recovered from the cleared lysate by centrifugation (100,000 × g for 30 min at 4°C), resuspended in lysis buffer, and
protein concentrations determined using the Bio-Rad protein assay
reagent (Bio-Rad, Hercules, CA). The concentration of the proteins was
adjusted to 0.8 mg/ml in lysis buffer and frozen as aliquots (500 µl)
at
80°C. To carry out the coimmunoprecipitation assay, membranes
(0.4 mg) were raised to 1 ml in immunoprecipitation (IP) dilution
buffer (1% Triton X-100, 150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH 7.5, 3 µg/ml leupeptin, 3 µg/ml pepstatin, 3 µg/ml chymostatin, 2 µg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride) and the
immunoprecipitation carried out as described previously (Loayza
et al., 1998
) except that 4 µl of rabbit anti-GFP
polyclonal antibodies was added to each sample. Immunoprecipitates were
dissociated from the protein A-Sepharose beads by the addition of 40 µl of 2 × Laemmli sample buffer and incubated at 65°C for 10 min before electrophoresis. Proteins were separated by 10% SDS-PAGE
and immunoblots were prepared as described previously
(Fujimura-Kamada et al., 1997
). The N-terminal cleavage
product of Ycf1p was detected with rat anti-HA monoclonal antibodies
(1:250). Nonspecific interactions with Vph1p were examined with mouse
anti-Vph1p monoclonal antibodies (1:5000).
Growth Inhibition by Cadmium
To examine growth on plates, cells were grown overnight to saturation in minimal medium, and then subcultured at a 1:500 dilution in minimal medium and grown overnight at 30°C to an OD600 of ~1.0. This overnight culture was diluted to an OD600 of 0.1, which in turn was diluted in 10-fold increments. Aliquots (5 µl) of each 10-fold dilution were spotted onto synthetic complete minimal medium containing 0 and 40 µM CdSO4 and incubated at 30°C for 3 or 6 d, respectively.
| |
Results |
|---|
|
|
|---|
Posttranslational Proteolytic Processing of Ycf1p Is PEP4 Dependent
To facilitate localization and processing studies, we generated a
C-terminally GFP-tagged version of Ycf1p (Figure 1A). Like untagged
Ycf1p (Li et al., 1996
; Wemmie and Moye-Rowley, 1997
), Ycf1p-GFP localizes to the vacuolar membrane, as evidenced by the
correspondence of the fluorescence pattern with the indentation of the
vacuole detectable by differential interference contrast (DIC)
microscopy (Figure 1B). In addition, Ycf1p-GFP is active in conferring
cadmium resistance (Figure 1C). Using this construct to further examine
the posttranslational processing of Ycf1p, we find that the majority of
Ycf1p-GFP is in the proteolytically processed form under steady-state
conditions (Figure 2, lane 1), as reported previously for untagged
Ycf1p (Wemmie and Moye-Rowley, 1997
).
The proteolytic processing of Ycf1p is unusual because the size of the
C-terminal cleavage product (~160 kDa) indicates that a large portion
of the protein, including the hydrophobic NTE plus additional residues,
is released upon cleavage. To determine whether proteolytic processing
occurs once Ycf1p reaches its final destination within the cell, we
examined the processing of Ycf1p in two different vacuolar
protease-deficient strains, pep4
or prb1
.
Pep4p, the master vacuolar protease, and the protease Prb1p play
reciprocal roles in activating each other and are responsible for
activating numerous other vacuolar proteases (Jones et al., 1997
). In the absence of either of these proteases, Ycf1p is not cleaved (Figure 2, lanes 2 and 3). Because Ycf1p properly localizes to
the vacuolar membrane in the pep4
and prb1
strains (our unpublished data), the lack of processing must not be due
to mislocalization. In addition, the C-terminal proteolytic product of
Ycf1p is generated in both the end3 and isogenic wild-type
strains at the nonpermissive temperature (Figure 2, lanes 4 and 5).
Thus, in contrast to previously published data (Wemmie and Moye-Rowley,
1997
), we found that cleavage of Ycf1p is PEP4 dependent and
that processing is not affected in an endocytosis-deficient
end3ts mutant strain. We expect that the
processing block observed in the previous study was actually due to a
PEP4 deletion because the end3-1 mutant strain
that was used (RH1834) was also a pep4 mutant.
We examined the kinetics of Ycf1p proteolytic processing by carrying
out metabolic labeling and pulse-chase analysis. In the wild-type
strain (PEP4), full-length Ycf1p chases into the C-terminal cleavage product and, as expected, no processing is observed in the
pep4
strain at any of the time points examined (Figure
3A). As full-length Ycf1p disappears, the
amount of the C-terminal proteolytic product increases, indicating a
precursor-product relationship between the two molecules (Figure 3B).
The apparent discrepancy between the amount of the C-terminal cleavage
product accumulated by 60 min compared with the amount of full-length Ycf1p at time 0 is primarily due to the difference in the number of
35S-labeled cysteines and methionines contained
in each piece, i.e., the full-length molecule has a combined total of
54 cysteines and methionines, whereas the C-terminal cleavage product
has only 40. Taken together, the immunoblot and
immunoprecipitation analyses indicate that Ycf1p proteolytic processing
occurs at the vacuole (i.e., is dependent on vacuolar protease), and
therefore cleavage can serve as a marker for vacuolar localization of
Ycf1p.
|
Proteolytic Processing of Ycf1p Yields Two Stable Cleavage Products That Associate with Each Other
To determine whether the N- and C-terminal Ycf1p cleavage products
are metabolically stable and/or interact with one another, we first
tagged Ycf1p-GFP with a triple HA epitope in its N-terminal cytosolic
loop (Figure 4A). This construct
localizes to the vacuole, retains activity (our unpublished data;
Figure 8, row 2) and permits us to follow the N- and C-terminal
proteolytic products with antibodies to HA and GFP, respectively. The
predicted Ycf1p cleavage site, indicated by the asterisk (*) in loop 6 (Figure 4A), is based on the SDS-PAGE mobility of the N- and C-terminal
cleavage products (Figure 4B) and on the requirement for a lumenal
processing site that is accessible to vacuolar proteases. Thus, the
N-terminal cleavage product includes MSD0, L0, and the first
transmembrane span of MSD1, whereas the C-terminal cleavage product
includes the majority of the core region of Ycf1p, but lacks the first transmembrane span of MSD1.
|
We first assessed the stability of the N- and C-terminal proteolytic products by using a cycloheximide chase experiment (Figure 4B). The fate of the Ycf1p species present at steady state (Figure 4B, lane 1) could be monitored by adding cycloheximide to stop protein synthesis and then by removing aliquots at the indicated time points. Full-length Ycf1p (detected with GFP or HA antibodies) disappears by 60 min. In contrast, the N- and C-terminal proteolytic products are stable during the chase period (Figure 4B, bottom and top, respectively). This metabolic stability of the N- and C-terminal cleavage products suggests that both are likely to contribute to the biological properties of Ycf1p.
To determine whether the N- and C-terminal cleavage products interact with each other once Ycf1p is processed, we performed a coimmunoprecipitation experiment in which immunoprecipitation with anti-GFP antibodies was followed by probing the immunoblot with anti-HA antibodies (Figure 4C). To ensure that the majority of Ycf1p in the starting material was in the processed form, we performed a 60-min cycloheximide chase before the preparation of crude membranes and immunoprecipitation of the C-terminal proteolytic product of Ycf1p. As shown in the immunoblot analysis of this immunoprecipitate, the N- and C-terminal proteolytic products of Ycf1p seem to efficiently coimmunoprecipitate, suggesting that they interact with each other after cleavage occurs (Figure 4C, top, lane 3). We also checked for nonspecific interactions in the immunoprecipitated material by examining the presence of an abundant vacuolar membrane protein, Vph1p. A comparable amount of Vph1p is detected in the input and unbound lanes and is absent from the IP lane, indicating that Vph1p does not interact with Ycf1p (Figure 4C, bottom, lanes 1-3). We conclude that the interaction between the N- and C-terminal proteolytic products of Ycf1p is specific. The interaction of the cleavage products further supports the hypothesis that both contribute to Ycf1p function.
Coexpression of Ycf1p Partial Molecules Is Required for Proper Trafficking to the Vacuole, as Assessed by Proteolytic Processing and Stability of Ycf1p
The results described above showing Pep4p-dependent proteolytic
processing of Ycf1p indicate that the C-terminal cleavage product can
serve as a marker for the proper vacuolar localization of Ycf1p. The
localization of Ycf1p can also be assessed by its fluorescence pattern.
To examine whether the MSD0 and/or L0 subregions of the NTE play a role
in trafficking of Ycf1p to the vacuole, we modeled our approach on that
taken by others to study human MRP1 (Bakos et al., 1998
; Gao
et al., 1998
). This approach involves the construction and
characterization of deletion mutants that we designate partial
molecules. The partial molecules of Ycf1p that we generated are shown
in Figure 5A. The constructs in rows 2 and 3 are distinguished by the attachment of L0 to the Ycf1p core
(
Ycf1p) or to MSD0, respectively.
|
We first examined the SDS-PAGE pattern of the Ycf1p
partial molecules expressed singly and together. Notably, the
proteolytic processing of the C-terminal partial molecules, L0-
Ycf1p
and
Ycf1p (Figure 5A, rows 2 and 3, respectively), is dramatically increased upon coexpression with their corresponding N-terminal partial
molecules that contain MSD0 (Figure 5B, lanes 3-6, bottom band). In
addition, coexpression notably increases the steady-state level of
these C-terminal partial molecules (Figure 5B, lanes 3-6).
Reciprocally, the steady-state level of the N-terminal partial molecules, MSD0 and MSD0-L0, is also greatly enhanced by the presence of their corresponding C-terminal partial molecules (Figure 5C, lanes
3-6). Together, these results indicate that coexpression is required
for efficient proteolytic processing of the Ycf1p C-terminal partial
molecules and to stabilize both the N- and C-terminal partial
molecules. Thus, it seems that MSD0 is critical for the targeting of
L0-Ycf1p or
Ycf1p to the vacuolar membrane. MSD0 could contain
specific targeting information or contribute to the proper folding of Ycf1p.
MSD0 Is Required for Vacuolar Localization of Ycf1p, but L0 Is Not
The immunoblot analyses (Figure 5B) indicate that
processing of the Ycf1p C-terminal partial molecules is greatly
enhanced by coexpression with their corresponding N-terminal partial
molecules, suggesting that coexpression leads to vacuolar localization
whereupon proteolytic processing can occur. This hypothesis implies
that the N- and C-terminal partial molecules are mislocalized when expressed alone, perhaps because they are misfolded and subjected to
various cellular quality control systems that lead to degradation (Hurtley and Helenius, 1989
; Chang and Fink, 1995
; Hammond and Helenius, 1995
; Li et al., 1999
). To test this hypothesis,
we visually examined the GFP fluorescence pattern of the C-terminal partial molecules when expressed alone or together with their corresponding N-terminal partial molecules (Figures
6 and 7).
|
|
We first consider our findings with the C-terminal partial molecules
expressed alone. Neither L0-
Ycf1p nor
Ycf1p is predominantly vacuolar (Figures 6A and 7A). Instead, both seem to mislocalize to
intracellular punctate structures whose exact identity is presently unknown, but seem to be largely endosomal based on staining with the
lipophilic dye FM4-64 (our unpublished data). Based on
immunofluorescence with the ER marker Kar2p, we cannot exclude the
possibility that some of the C-terminal partial molecules could also be
endoplasmic reticulum associated. In a small percentage of cells these
partial molecules showed vacuolar localization that correlates with the low level of processing observed by immunoblot analysis
(Figure 5B) and could suggest that a minor population of the C-terminal partial molecules reach the vacuole on their own. By indirect immunofluorescence microscopy, we observe that the N-terminal partial
molecules MSD0 and MSD0-L0 also generally mislocalize to intracellular
structures when expressed alone (our unpublished data). Importantly,
the mislocalization we observe for L0-
Ycf1p shows that even though
L0 is present, it is not sufficient for proper trafficking of Ycf1p in
the absence of MSD0. Instead, MSD0 seems to be the key determinant for
the vacuolar localization of Ycf1p.
Next, we consider the localization of the C-terminal partial molecules when coexpressed with their corresponding N-terminal partial molecules. There was a striking shift in the localization pattern of the C-terminal partial molecules from intracellular structures to the vacuolar membrane upon coexpression with their corresponding N-terminal partial molecules (Figures 6B and 7B). This shift in localization correlates precisely with the dramatic increase in proteolytic processing observed upon coexpression of the partial molecules and confirms that processing serves as a reliable marker for vacuolar localization (Figure 5B). Likewise, we observed by indirect immunofluorescence that the N-terminal partial molecules MSD0 and MSD0-L0 also shift in localization from intracellular structures to the vacuole when coexpressed with their corresponding C-terminal partial molecule (our unpublished data). Thus, the N- and C-terminal partial molecules are mutually dependent on each other for proper vacuolar localization.
To determine whether the MSD0 segment of the NTE is sufficient alone
for the vacuolar localization of
Ycf1p, we coexpressed MSD0 with
Ycf1p, two partial molecules that both lack L0. The fluorescence
pattern clearly indicates that the MSD0 portion of the NTE suffices to
target the majority of
Ycf1p to the vacuolar membrane (Figure 7C).
Taken together, the results of these studies demonstrate that MSD0 is
required and that L0 is dispensable for targeting Ycf1p to the vacuolar membrane.
L0 Is Required for Function of Ycf1p
Ycf1p confers cadmium resistance by transporting
cadmium-glutathione complexes into the vacuole (Li et al.,
1997
). To test the ability of the partial molecules to mediate
transport function we examined their activity by plating cells on
cadmium-containing medium. Ten-fold serial dilutions of the strains
were spotted onto plates lacking CdSO4 to ensure
the growth properties of the strains were similar, and on plates with
40 µM CdSO4 to test their resistance to
cadmium. As expected, cells lacking Ycf1p (ycf1
) are
sensitive to cadmium, whereas cells expressing wild-type Ycf1p on a
multicopy plasmid are cadmium resistant (Figure
8, rows 1 and 2, respectively). None of
the partial molecules are functional when expressed alone (Figure 8,
rows 3, 4, 6, and 7). However, coexpression of MSD0 with L0-
Ycf1p or
MSD0-L0 with
Ycf1p restores cellular resistance to cadmium (Figure
8, rows 5 and 8, respectively). We could also test the cadmium
phenotype of Ycf1p when L0 is missing altogether by expressing the MSD0
and
Ycf1p combination of partial molecules. On coexpression of MSD0
with
Ycf1p, we observe no growth in the presence of cadmium (Figure
8, row 9), even though by microscopy this combination of partial
molecules localizes efficiently to the vacuole (Figure 7C). These
results provide strong evidence that L0 is required for Ycf1p to confer
resistance to cadmium.
|
Taken together, the above-mentioned results indicate that although
vacuolar localization can be achieved independently of L0, Ycf1p
function is absolutely dependent on the presence of L0. This result
agrees with the finding that L0 is critical for human MRP1 activity,
based on studies with MRP1 partial molecules (Bakos et al.,
1998
). An essential role for L0 in MRP transport activity was confirmed
by examining various internal deletions of L0 (Gao et al.,
1998
; Bakos et al., 2000
; Qian et al., 2001
). Bakos et al. (2000)
further showed that this cytosolic
linker region (L0) associates with membranes on its own, suggesting
that L0 forms a distinct functional domain that interacts with the cell
membrane or with hydrophobic regions of other membrane proteins. Within
L0, a region predicted to form an amphipathic alpha-helix was
specifically shown to be critical for the transport activity of MRP1
(Figure 9B; Bakos et al.,
2000
). Interestingly, based on sequence alignments we find that MRP1
and Ycf1p share a high degree of similarity in L0, particularly in the
region predicted to form a helical wheel (Figure 9A). In fact, computer
predictions (www.marqusee9.berkeley.edu/kael/helical.htm) indicate that
this region in Ycf1p, like that of MRP1, forms an amphipathic
alpha-helix as well (Figure 9B). An internal deletion of the helical
wheel in Ycf1p (
223-235) abolishes the ability of Ycf1p to confer
resistance to cadmium (Figure 8, row 10) even though it has no effect
on the vacuolar localization of Ycf1p (our unpublished data). This result further demonstrates the functional significance of L0.
|
| |
DISCUSSION |
|---|
|
|
|---|
Structure-function analyses of numerous ABC proteins have revealed that the ABC "core" comprising two MSDs and two NBDs contains critical components for proper localization, ATP hydrolysis, and substrate transport. However, a universal role for the N-terminal extension (MSD0-L0) present in certain MRP subfamily members, such as Ycf1p, has not been clearly established, and indeed may differ from one MRP protein to another. In this study, we have established a role for MSD0 in targeting Ycf1p to the vacuolar membrane, and for L0 in Ycf1p cadmium resistance function. In addition, we show that Ycf1p undergoes an unusual proteolytic processing event that is mediated by vacuolar proteases and yields two stable products that associate with one another after cleavage. The functional consequences of processing, or lack thereof, are examined elsewhere (Mason and Michaelis, manuscript in preparation). Herein, we use processing as a convenient marker to signify proper trafficking to the vacuolar membrane. Below we consider our findings first in terms of Ycf1p per se and then compare our results to findings on human MRP1 and MRP2.
MSD0 Is Required for Localization of Ycf1p
The importance of MSD0 for Ycf1p localization was determined by expressing partial molecules of Ycf1p separately and together, similar to the approach used to study human MRP1. In this approach, the N-terminal partial molecules contain MSD0 and the C-terminal partial molecules contain the ABC core domain, whereas L0 is attached to either MSD0 or to the core domain. Direct and indirect fluorescence microscopy indicates that all of the Ycf1p partial molecules are mislocalized when expressed alone (Figures 6A and 7A; our unpublished data). However, we observed a striking vacuolar membrane localization when the corresponding N- and C-terminal partial molecules were coexpressed (Figures 6B and 7B). We also observed an increase in the proteolytic processing of Ycf1p by immunoblot analysis when the partial molecules were coexpressed (Figure 5B), which correlates with the increase in their trafficking to the vacuole observed by microscopy. This dramatic shift to the vacuole implies that the partial molecules can, and indeed must, interact with each other when they are coexpressed to form a properly folded molecule. Thus, our results clearly indicate a requirement for MSD0 for vacuolar localization of Ycf1p.
Importantly, the coexpression of two partial molecules that each lack
L0 (MSD0 and
Ycf1p) was sufficient for localizing Ycf1p to the
vacuolar membrane (Figure 7C). These results strongly support an
essential role for MSD0 in targeting Ycf1p to the vacuolar membrane and
indicate that L0 is dispensable for localization of Ycf1p. Our
conclusions contradict those of a previous study that suggested that
the L0 region was required for vacuolar localization of Ycf1p (Wemmie
and Moye-Rowley, 1997
). Because the exact same amino acids and length
of L0 was used in both studies, the discrepancy cannot be due to
differences in the particular region chosen as L0. Several explanations
could be possible, including strain differences and/or subtle
physiological differences due to media or growth conditions. Whatever
the explanation for the discrepancy, our data strongly supports a
requirement for MSD0 for the majority of Ycf1p to reach its proper
vacuolar membrane localization, under normal physiological conditions.
L0 Is Important for Activity of Ycf1p
To ask about a functional requirement for L0 we tested the cadmium
resistance in a strain coexpressing partial molecules (MSD0 and
Ycf1p) that both lack L0. We did not observe any cadmium resistance
(Figure 8, row 9), even though vacuolar targeting was normal (Figure
7C). Immunoblot analysis indicated that coexpression also
resulted in an increase in the steady-state protein levels of each
partial molecule (our unpublished data), but not to the same dramatic
extent as when either molecule contained L0, suggesting that L0 may
also play a role in stabilization of Ycf1p. Although the modest
destabilization of MSD0 and
Ycf1p in the absence of L0 could make a
minor contribution to reducing cadmium resistance, it is unlikely to
account for the essentially complete elimination in cadmium resistance
that we observed upon coexpression of MSD0 and
Ycf1p. In contrast,
coexpression of essentially the same N- and C-terminal partial
molecules, but with L0 attached to either MSD0 or
Ycf1p (Figure 8,
rows 5 and 8), exhibits cadmium resistance indistinguishable from wild
type. Thus, our data suggest that L0 plays a key role in modulating
Ycf1p transport activity.
We further defined the region within L0 that is critical for activity
by creating an internal deletion in L0. The activity of Ycf1p was
abolished when we deleted a 13-amino acid region predicted to form an
amphipathic alpha-helix within L0 (Figure 9 and Figure 8, row 10).
Thus, similar to human MRP1 (Bakos et al., 2000
; see below),
L0 may form an important structural domain that could interact with
other hydrophobic regions of Ycf1p. Our data suggest that this domain
and/or these interactions are necessary for Ycf1p activity. Although we
have shown that the L0 portion of the N-terminal extension,
specifically the region predicted to form an amphipathic alpha-helix,
is required for Ycf1p-mediated cadmium resistance, we were unable to
determine whether L0 is sufficient for activity, because L0-
Ycf1p,
which lacks solely MSD0, is mislocalized to intracellular structures,
precluding a meaningful in vivo functional test.
Comparison of Roles of MSD0 and L0 of Yeast Ycf1p and Human MRP1
Several studies have specifically examined the significance of the
N-terminal extension in MRP1, the closest human homologue of Ycf1p. The
most definitive of these used partial constructs, which served as the
prototype for those used herein. MSD0 was not required for localization
of MRP1 to the basolateral membrane, nor for its glutathione-conjugate
transport activity (Bakos et al., 1998
). Because only one
cell type was examined, MSD0 could still be required for the
localization of MRP1 to the plasma membrane in other cell types, as
noted by the authors. Interestingly, a recent report examined the
functional significance of the NTE in human MRP2. The results of that
study strikingly parallel our findings with Ycf1p, in that MSD0 was
shown to play a key role in MRP2 trafficking, in this case to the
apical membrane of MDCKII cells (Fernandez et al., 2002
).
Taken together, these studies provide evidence that MSD0 is required
for the proper trafficking of at least a subset of MRP subfamily
members, both in yeast and humans.
The cytosolic linker region L0 has been directly implicated in both the
localization and transport activity of human MRP1 (Bakos et
al., 1998
). Recently, an amphipathic helical membrane-attaching region within L0 of MRP1 was shown to be critical for the glutathione transport activity of MRP1 (Bakos et al., 2000
). Likewise,
we have demonstrated that the homologous amphipathic helical region within L0 of Ycf1p is critical for transport activity of Ycf1p, as
determined by monitoring cadmium resistance. The striking similarity of
the L0 region of yeast Ycf1p compared with that of human MRP1 further
validates the utility of yeast as a model system to understand the
functional domains of MRP proteins.
The N- and C-Terminal Cleavage Products of Ycf1p Associate with Each Other
Proteolytic processing of Ycf1p has been observed in a previous
study (Wemmie and Moye-Rowley, 1997
). An important aspect of the
present study was to further examine the rather surprising posttranslational proteolytic processing event that cleaves Ycf1p within the conserved ABC core. To date, no other ABC proteins have been
found to undergo an analogous processing event. Gel mobility of the
cleavage product suggests that cleavage occurs within the first lumenal
loop of MSD1 to liberate MSD0, L0, and the first transmembrane span of
MSD1. We determined that this cleavage is PEP4 dependent in
three different strain backgrounds (Figures 2 and 3; our unpublished
data). It is unclear why processing was not blocked in the
pep4
strain of Wemmie and Moye-Rowley (1997)
.
Nevertheless, our data clearly indicate that the processing of Ycf1p is
dependent on the master vacuolar proteases Pep4p and Prb1p and
illustrate that cleavage can be used as a marker for vacuolar
localization. Importantly, we found that this cleavage produces two
stable products that directly interact (Figure 4) as assessed by
coimmunoprecipitation. This result, together with our finding that L0
is required for activity and the known functional importance of the
NBDs (Falcon-Perez et al., 1999
, 2001
), indicate that
multiple regions of Ycf1p must associate with one another to form an
active transporter.
| |
ACKNOWLEDGMENTS |
|---|
We thank G. Huyer for critical reading of the manuscript. S.M. was supported by a grant (DK-58029) from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: michaelis{at}jhmi.edu.
DOI: 10.1091/mbc.E02-07-0405.
| |
REFERENCES |
|---|
|
|
|---|